Qianxing Mo

机构：Moffitt Cancer Center · ORCID：0000-0002-0021-7694

发表论文 391 篇 · 总被引 15962 次 · h-index 52

代表论文

A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T‐Cell Lymphoma (2026 · Hematological Oncology)
Lineage tracing reveals a shared cellular origin for supraclavicular brown and inguinal beige adipocytes (2026 · Cell Reports)
Supplementary Figure 8 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents (2026)
Supplementary Figure 4 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents (2026)
Supplementary Figures S1-S4 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis (2026)
Supplementary Figure 12 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents (2026)